BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 17125723)

  • 1. Effectiveness and benefit-cost of peer-based workplace substance abuse prevention coupled with random testing.
    Miller TR; Zaloshnja E; Spicer RS
    Accid Anal Prev; 2007 May; 39(3):565-73. PubMed ID: 17125723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current practice and experience in drug and alcohol testing in the workplace.
    Zwerling C
    Bull Narc; 1993; 45(2):155-96. PubMed ID: 7920540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a workplace peer-focused substance abuse prevention and early intervention program.
    Spicer RS; Miller TR
    Alcohol Clin Exp Res; 2005 Apr; 29(4):609-11. PubMed ID: 15834226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the EAP in the identification and treatment of substance abuse.
    Kramer RM
    Clin Lab Med; 1998 Dec; 18(4):747-53, x. PubMed ID: 9891612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charting the sea of employee addiction.
    Russo V; Halpern Z
    Occup Health Saf; 1992 Dec; 61(12):35-6, 65. PubMed ID: 1475070
    [No Abstract]   [Full Text] [Related]  

  • 6. Employer costs of alcohol-involved injuries.
    Zaloshnja E; Miller TR; Hendrie D; Galvin D
    Am J Ind Med; 2007 Feb; 50(2):136-42. PubMed ID: 17187380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance abuse in the workplace: epidemiology, effects, and industry response.
    Bush DM; Autry JH
    Occup Med; 2002; 17(1):13-25, iii. PubMed ID: 11726333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs and alcohol in the workplace.
    Conry PB
    AAOHN J; 1991 Oct; 39(10):461-5. PubMed ID: 1930379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-benefit analysis of a California county's back injury prevention program.
    Shi L
    Public Health Rep; 1993; 108(2):204-11. PubMed ID: 8464977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of substance abuse patterns, medical expenses and effectiveness of treatment in the workplace: long-term followup.
    Worner TM; Chen PJ; Ma H; Xu S; McCarthy EG
    Empl Benefits J; 1993 Dec; 18(4):15-9. PubMed ID: 10171744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between employer health insurance characteristics and the provision of employee assistance programs.
    Zarkin GA; Garfinkel SA
    Inquiry; 1994; 31(1):102-14. PubMed ID: 8168905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A workplace breast cancer screening program. Costs and components.
    Schrammel P; Griffiths RI; Griffiths CB
    AAOHN J; 1998 Nov; 46(11):523-9. PubMed ID: 9934000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of substance abuse patterns, medical expenses and effectiveness of treatment in the workplace.
    Yu J; Chen PJ; Harshman EJ; McCarthy EG
    Empl Benefits J; 1991 Sep; 16(3):26-30. PubMed ID: 10170845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trauma in the workplace. An overview.
    Howell E; Brown K; Atkins J
    AAOHN J; 1990 Oct; 38(10):467-74. PubMed ID: 2222580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for evaluating a mature substance abuse prevention/early intervention program.
    Becker LR; Hall M; Fisher DA; Miller TR
    J Behav Health Serv Res; 2000 May; 27(2):166-77. PubMed ID: 10795127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worksite influenza immunization programs. Insight into the implementation and cost-benefit.
    Olsen GW; Steinberg ME; Ley CA
    AAOHN J; 2005 Mar; 53(3):105-10. PubMed ID: 15789965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minnesota workplace drug testing. Analysis of policy and procedures.
    Reynolds JL; McGovern PM; Kochevar L; Olson DK; Hibbs BF
    AAOHN J; 1991 Nov; 39(11):523-33. PubMed ID: 1930387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of preemployment drug screening in the prediction of employment outcome.
    Leigh JP
    J Occup Med; 1993 Oct; 35(10):983-4. PubMed ID: 8271080
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug use: association vs causation.
    Ryan J; Zwerling C; Jones M
    J Occup Med; 1993 Oct; 35(10):984. PubMed ID: 8271081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 36.